SCHEMBL5906839

SCHEMBL5906839

COC(=O)[C@@H](Cc1ccccc1)Nc1cc(Cl)ncn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 2/20 0.52
ITGA4 P13612 2/20 0.52
ATM Q13315 1/20 0.47
ALDH1A1 P00352 3/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
THRB P10828 1/20 0.46
HSD17B10 Q99714 1/20 0.46
NOS2 P35228 3/20 0.46
NOS3 P29474 1/20 0.46
NOS1 P29475 1/20 0.46
POLB P06746 1/20 0.45
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
KMT2A Q03164 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
ALOX15 P16050 1/20 0.45
PYGL P06737 1/20 0.44
CYP3A4 P08684 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5906642 1.00 ITGB1 (0.52) ITGB1ITGA4ATMALDH1A1CYP2C9
SCHEMBL5906645 1.00 ITGB1 (0.52) ITGB1ITGA4ATMALDH1A1CYP2C9
SCHEMBL5906864 0.85 HDAC6 (0.53) ITGB1ITGA4LMNARAB9A
SCHEMBL5031501 0.83 ATM (0.45) ATMALDH1A1CYP2C9CYP2C19THRB
SCHEMBL5906841 0.81 TACR3 (0.47) ITGB1ITGA4ATMALDH1A1CYP2C19
SCHEMBL5906697 0.81 TACR3 (0.47) ITGB1ITGA4ATMALDH1A1CYP2C19
SCHEMBL5906767 0.81 ELANE (0.48) ITGB1ITGA4ATMALDH1A1CYP2C19
SCHEMBL5906861 0.81 ELANE (0.48) ITGB1ITGA4ATMALDH1A1CYP2C19
SCHEMBL5906837 0.81 TACR3 (0.47) ITGB1ITGA4ATMALDH1A1CYP2C19
SCHEMBL5906701 0.81 TACR3 (0.47) ITGB1ITGA4ATMALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BAYER HEALTHCARE AG (DE) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089371-A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist BPHL, HRH4, HRH2 ITGB1 1017/4885ITGA4 347/4885ATM 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.